Home
Conditions
Sarcoma, Soft Tissue

Clinical trial condition

Sarcoma, Soft Tissue

Explore clinical trials studying Sarcoma, Soft Tissue. Study availability and eligibility vary by location and protocol.

36 public trials 6 recruiting studies

Refine in advanced search Browse all conditions

Sarcoma, Soft Tissue trial results

Completed

A Study of Olaratumab in Soft Tissue Sarcoma

NCT01185964

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, +2 more
Locations: ImClone Investigational Site Tucson, Arizona, United States

ImClone Investigational Site Los Angeles, California, United States

ImClone Investigational Site Aurora, Colorado, United States

ImClone Investigational Site Gainesville, Florida, United States

View all 17 locations

View Trial Details

Completed

Pazopanib In Patients With Relapsed Or Refractory Soft Tissue Sarcoma

NCT00297258

Conditions: Leiomyosarcoma, Neoplasms, Neoplasms by Histologic Type, +6 more
Locations: GSK Investigational Site Brussels, Belgium

GSK Investigational Site Leuven, Belgium

GSK Investigational Site Lyon, France

GSK Investigational Site Marseille, France

View all 16 locations

View Trial Details

Completed

Evaluation of Side Effects and Relative Activity of Two Chemotherapy Regimens in the Treatment Soft Tissue Sarcoma

NCT00189137

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, +2 more
Locations: University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States

View Trial Details

Completed

Everolimus for Treating Pediatric Patients With Recurrent or Refractory Tumors

NCT00187174

Conditions: Brain Diseases, Brain Neoplasms, Brain Tumors, +18 more
Locations: St. Jude Children's Research Hospital Memphis, Tennessee, United States

View Trial Details

Completed

Study of AP23573/MK-8669 (Ridaforolimus), A Mammalian Target of Rapamycin (mTOR) Inhibitor, in Participants With Advanced Sarcoma (MK-8669-018 AM1)(COMPLETED)

NCT00093080

Conditions: Leiomyosarcoma, Liposarcoma, Metastases, +14 more
Locations: Not specified

View Trial Details

Completed

Pazopanib Versus Placebo in Patients With Soft Tissue Sarcoma Whose Disease Has Progressed During or Following Prior Therapy

NCT00753688

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, +2 more
Locations: GSK Investigational Site Birmingham, Alabama, United States

GSK Investigational Site Los Angeles, California, United States

GSK Investigational Site Orange, California, United States

GSK Investigational Site Santa Monica, California, United States

View all 81 locations

View Trial Details

Completed

Chemotherapy Drug Sensitivity Microculture (MiCK) Assay for Apoptosis

NCT00243685

Conditions: Adnexal Diseases, Breast Diseases, Breast Neoplasms, +25 more
Locations: Nashville Breast Center Nashville, Tennessee, United States

Nashville Oncology Associates Nashville, Tennessee, United States

Cancer Care Centers of South Texas San Antonio, Texas, United States

View Trial Details

Completed

BAY-43-9006 in Advanced, Metastatic Soft Tissue Sarcomas

NCT00406601

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, +2 more
Locations: Istituto Clinico Humanitas Rozzano, Milan, Italy

View Trial Details

Completed

TLC D-99 and Ifosfamide in Metastatic Soft Tissue Sarcoma Patients

NCT00289809

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, +2 more
Locations: Istituto Clinico Humanitas Rozzano, Milan, Italy

View Trial Details

Completed

a Multicenter Clinical Trial for the Treatment of Children and Adolescents With Soft Tissue Sarcoma Stage 4

NCT00130858

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, +2 more
Locations: HELIOS Klinikum Erfurt GmbH Erfurt, Saxony, Germany

Zentralklinikum Augsburg, Germany

Klinikum Berlin-Buch Berlin, Germany

Virchow Klinik Berlin, Germany

View all 38 locations

View Trial Details

Sarcoma, Soft Tissue

Sarcoma, Soft Tissue trial results

Related conditions